[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2001256998A1 - Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death - Google Patents

Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death

Info

Publication number
AU2001256998A1
AU2001256998A1 AU2001256998A AU5699801A AU2001256998A1 AU 2001256998 A1 AU2001256998 A1 AU 2001256998A1 AU 2001256998 A AU2001256998 A AU 2001256998A AU 5699801 A AU5699801 A AU 5699801A AU 2001256998 A1 AU2001256998 A1 AU 2001256998A1
Authority
AU
Australia
Prior art keywords
diagnosing
disorders
compositions
methods
cell death
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001256998A
Inventor
Shawn Barney
Lawrence C. Katz
Donald C. Lo
Stuart D. Portbury
Kasturi Puranam
Mary Beth Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cogent Neuroscience Inc
Original Assignee
Cogent Neuroscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cogent Neuroscience Inc filed Critical Cogent Neuroscience Inc
Publication of AU2001256998A1 publication Critical patent/AU2001256998A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AU2001256998A 2000-04-11 2001-04-09 Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death Abandoned AU2001256998A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54793800A 2000-04-11 2000-04-11
US09547938 2000-04-11
PCT/US2001/011501 WO2001081361A1 (en) 2000-04-11 2001-04-09 Compositions and method for diagnosing and treating conditions, disorders, or diseases involving cell death

Publications (1)

Publication Number Publication Date
AU2001256998A1 true AU2001256998A1 (en) 2001-11-07

Family

ID=24186756

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001256998A Abandoned AU2001256998A1 (en) 2000-04-11 2001-04-09 Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death

Country Status (2)

Country Link
AU (1) AU2001256998A1 (en)
WO (1) WO2001081361A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003097687A2 (en) * 2002-05-16 2003-11-27 Ikuo Nishimoto Neuroprotective polypeptides and methods of use
US8309525B2 (en) 2007-05-30 2012-11-13 Albert Einstein College Of Medicine Of Yeshiva University Treatment of type 2 diabetes, metabolic syndrome, myocardial injury and neurodegeneration with humanin and analogs thereof
WO2009033791A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
US8637470B2 (en) 2008-05-01 2014-01-28 The Regents Of The University Of California Small humanin-like peptides
WO2021030799A1 (en) * 2019-08-15 2021-02-18 Cohbar, Inc. Therapeutic peptides
WO2021030792A1 (en) * 2019-08-15 2021-02-18 Cohbar, Inc. Therapeutic peptides
WO2021030749A1 (en) * 2019-08-15 2021-02-18 Cohbar, Inc. Therapeutic peptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993016178A2 (en) * 1992-02-12 1993-08-19 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Sequences characteristic of human gene transcription product

Also Published As

Publication number Publication date
WO2001081361A8 (en) 2002-02-28
WO2001081361A1 (en) 2001-11-01
WO2001081361B1 (en) 2002-06-27

Similar Documents

Publication Publication Date Title
AU2085201A (en) Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
AU3998400A (en) Methods of treating c1s-mediated diseases and conditions, and compounds and compositions therefor
WO2005046434A8 (en) Compositions and methods for diagnosing and treating mental disorders
AU8003800A (en) Methods and compositions for treating neurobehavioral disorders
AUPS323902A0 (en) Compositions and methods for treating gynaecological disorders
AU2001260847A1 (en) Compositions isolated from skin cells and methods for their use
AU2001284865A1 (en) Methods for diagnosing and treating dysautonomia and other dysautonomic conditions
AU2001251507A1 (en) Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
AU2002235692A1 (en) Methods and compositions for preventing and treating neutrophil-mediated diseases
MXPA03003741A (en) Methods and compositions for the treatment of diseases of the eye.
AU2001237939A1 (en) Methods for treating glaucoma
WO2003039490A9 (en) Compositions and methods for diagnosing and treating mental disorders
EP1670894B8 (en) Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions
AU2001256998A1 (en) Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
AU2001251508A1 (en) Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
ZA200203435B (en) Method and compositions for treating pulmonary diseases.
AU4515001A (en) Compositions and methods for locally treating inflammatory diseases
AU2001283199A1 (en) Methods and compositions for the diagnosis and treatment of brown adipose cell disorders
AU2002312314A1 (en) Compositions and methods for preventing neural tube disorders
AU2003214920A1 (en) Methods and compositions for treating hematological disorders
AU2001238288A1 (en) Method and compositions for treating fibrotic diseases
AU2002316647A1 (en) Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
AU2002217915A1 (en) Compositions and methods for diagnosing or treating psoriasis
AU6385200A (en) Compositions, kits, and methods for prognostication, diagnosis, prevention, and treatment of bone-related disorders and other disorders
AU2002360665A1 (en) Methods for treating conditions, disorders, or diseases involving cell death